A Double-Blind, Randomized, Placebo-Controlled Phase 1 Study of Ad26.ZIKV.001, an Ad26-Vectored Anti–Zika Virus Vaccine

Posted on by

Annals of Internal Medicine
May 2021 Volume 174, Issue 5
http://annals.org/aim/issue

 

Original Research
A Double-Blind, Randomized, Placebo-Controlled Phase 1 Study of Ad26.ZIKV.001, an Ad26-Vectored Anti–Zika Virus Vaccine
Nadine C. Salisch, PhD, Kathryn E. Stephenson, MD, MPH, Kristi Williams, BSN, PhD, Freek Cox, PhD, … et al.
Pages:585–594

Major Update: Remdesivir for Adults With COVID-19 – A Living Systematic Review and Meta-analysis for the American College of Physicians Practice Points

Posted on by

Annals of Internal Medicine
May 2021 Volume 174, Issue 5
http://annals.org/aim/issue

Major Update: Remdesivir for Adults With COVID-19 – A Living Systematic Review and Meta-analysis for the American College of Physicians Practice Points
FREE

 

Anjum S. Kaka, MD, Roderick MacDonald, MS, Nancy Greer, PhD, Kathryn Vela, MLIS, … et al.

Methodological frontiers in vaccine safety: qualifying available evidence for rare events, use of distributed data networks to monitor vaccine safety issues, and monitoring the safety of pregnancy interventions

Posted on by

BMJ Global Health
May 2021 – Volume 6 – Suppl 2
https://gh.bmj.com/content/6/Suppl_2

 

Methodological frontiers in vaccine safety: qualifying available evidence for rare events, use of distributed data networks to monitor vaccine safety issues, and monitoring the safety of pregnancy interventions (19 May, 2021)
Caitlin Dodd, Nick Andrews, Helen Petousis-Harris, Miriam Sturkenboom, Saad B Omer, Steven Black

Novel vaccine safety issues and areas that would benefit from further research

Posted on by

BMJ Global Health
May 2021 – Volume 6 – Suppl 2
https://gh.bmj.com/content/6/Suppl_2

 

Novel vaccine safety issues and areas that would benefit from further research (19 May, 2021)
Daniel A Salmon, Paul Henri Lambert, Hanna M Nohynek, Julianne Gee, Umesh D Parashar, Jacqueline E Tate, Annelies Wilder-Smith, Kenneth Y Hartigan-Go, Peter G Smith, Patrick Louis F Zuber

Knowledge, attitude, and acceptance of healthcare workers and the public regarding the COVID-19 vaccine: a cross-sectional study

Posted on by

BMC Public Health
http://bmcpublichealth.biomedcentral.com/articles
(Accessed 22 May 2021)

 

Knowledge, attitude, and acceptance of healthcare workers and the public regarding the COVID-19 vaccine: a cross-sectional study
This study determined the knowledge, attitudes, and practice regarding COVID-19 and assessed the acceptance of the COVID-19 vaccine among healthcare workers and the general population.
Authors: Muhammed Elhadi, Ahmed Alsoufi, Abdulmueti Alhadi, Amel Hmeida, Entisar Alshareea, Mawadda Dokali, Sanabel Abodabos, Omaymah Alsadiq, Mohammed Abdelkabir, Aimen Ashini, Abdulhamid Shaban, Saja Mohammed, Nehal Alghudban, Eman Bureziza, Qasi Najah, Khawla Abdulrahman…
Citation: BMC Public Health 2021 21:955
Content type: Research
Published on: 20 May 2021

Primary care: Building capacity in evidence-based medicine in low-income and middle-income countries: problems and potential solutions

Posted on by

BMJ Evidence-Based Medicine
June 2021 – Volume 26 – 3
https://ebm.bmj.com/content/26/3

 

EBM opinion and debate
Primary care: Building capacity in evidence-based medicine in low-income and middle-income countries: problems and potential solutions (22 November, 2019)
Peter J Gill, Shabana M Ali, Yasmin Elsobky, Raymond C Okechukwu, Tatiane B Ribeiro, Augusto Cesar Soares dos Santos Junior, Daniel Umpierre, Georgia C Richards

Global genomic pathogen surveillance to inform vaccine strategies: a decade-long expedition in pneumococcal genomics

Posted on by

Genome Medicine
https://genomemedicine.biomedcentral.com/articles
[Accessed 22 May 2021]

 

Global genomic pathogen surveillance to inform vaccine strategies: a decade-long expedition in pneumococcal genomics
Vaccines are powerful agents in infectious disease prevention but often designed to protect against some strains that are most likely to spread and cause diseases. Most vaccines do not succeed in eradicating t…
Authors: Stephen D. Bentley and Stephanie W. Lo
Citation: Genome Medicine 2021 13:84
Content type: Review
Published on: 17 May 2021

COVID-19 and future pandemics: a global systems approach and relevance to SDGs

Posted on by

Globalization and Health
http://www.globalizationandhealth.com/
[Accessed 22 May 2021]

 

COVID-19 and future pandemics: a global systems approach and relevance to SDGs
The COVID-19 pandemic is adversely impacting modern human civilization. A global view using a systems science approach is necessary to recognize the close interactions between health of animals, humans and the…
Authors: Tharanga Thoradeniya and Saroj Jayasinghe
Citation: Globalization and Health 2021 17:59
Content type: Debate
Published on: 21 May 2021

How does globalization affect COVID-19 responses?

Posted on by

Globalization and Health
http://www.globalizationandhealth.com/
[Accessed 22 May 2021]

 

How does globalization affect COVID-19 responses?
The ongoing COVID-19 pandemic has highlighted the vast differences in approaches to the control and containment of coronavirus across the world and has demonstrated the varied success of such approaches in min…
Authors: Steve J. Bickley, Ho Fai Chan, Ahmed Skali, David Stadelmann and Benno Torgler
Citation: Globalization and Health 2021 17:57
Content type: Research
Published on: 20 May 2021

Disability inclusion in humanitarian action

Posted on by

Humanitarian Exchange Magazine
Number 78, October 2020
https://odihpn.org/magazine/inclusion-of-persons-with-disabilities-in-humanitarian-action-what-now/

 

Disability inclusion in humanitarian action
by HPN October 2020
The theme of this edition of Humanitarian Exchange, co-edited with Sherin Alsheikh Ahmed from Islamic Relief Worldwide, is disability inclusion in humanitarian action. Persons with disabilities are not only disproportionately impacted by conflicts, disasters and other emergencies, but also face barriers to accessing humanitarian assistance. At the same time, global commitments and standards and the IASC Guidelines on the inclusion of persons with disabilities in humanitarian action all emphasise how persons with disabilities are also active agents of change. Disability and age-focused organisations have led on testing and demonstrating how inclusion can be done better. Yet despite this progress, challenges to effective inclusion remain.

As Kirstin Lange notes in the lead article, chief among these challenges is humanitarian agencies’ lack of engagement with organisations of persons with disabilities. Simione Bula, Elizabeth Morgan and Teresa Thomson look at disability inclusion in humanitarian response in the Pacific, and Kathy Al Jubeh and Alradi Abdalla argue for a ‘participation revolution’, building on learning from the gender movement. Tchaurea Fleury and Sulayman AbdulMumuni Ujah outline how the Bridge Article 11 training initiative is encouraging constructive exchange between humanitarian and disability actors. The lack of good, disaggregated data is highlighted by Sarah Collinson; Frances Hill, Jim Cranshaw and Carys Hughes emphasise the need for training resources in local languages and accessible formats; and Sophie Van Eetvelt and colleagues report on a review of the evidence on inclusion of people with disabilities and older people.

Rebecca Molyneux and co-authors analyse the findings of a review of a DFID programme in north-east Nigeria, while Carolin Funke highlights the importance of strategic partnerships between disability-focused organisations, drawing on her research in Cox’s Bazar. Sherin Alsheikh Ahmed describes Islamic Relief Worldwide’s approach to mainstreaming protection and inclusion, while Pauline Thivillier and Valentina Shafina outline IRC’s Client Responsive Programming. The edition ends with reflections by Mirela Turcanu and Yves Ngunzi Kahashi on CAFOD’s SADI approach.

An Asia-Pacific study on healthcare workers’ perceptions of, and willingness to receive, the COVID-19 vaccination

Posted on by

International Journal of Infectious Diseases
Volume 106 p1-430
https://www.ijidonline.com/current

 

An Asia-Pacific study on healthcare workers’ perceptions of, and willingness to receive, the COVID-19 vaccination
Nicholas W.S. Chew, Clare Cheong, Gwyneth Kong, …Arvind K. Sharma, Roger C. Ho, Vijay K. Sharma
Published online: March 26, 2021
p52-60

SARS-CoV-2–Specific Antibodies in Breast Milk After COVID-19 Vaccination of Breastfeeding Women

Posted on by

JAMA
May 11, 2021, Vol 325, No. 18, Pages 1813-1912
https://jamanetwork.com/journals/jama/currentissue

 

Research Letter
SARS-CoV-2–Specific Antibodies in Breast Milk After COVID-19 Vaccination of Breastfeeding Women
Sivan Haia Perl, MD; Atara Uzan-Yulzari, MSc; Hodaya Klainer, BSc; et al.
free access has active quiz
JAMA. 2021;325(19):2013-2014. doi:10.1001/jama.2021.5782
This prospective study investigated whether antibodies from SARS-CoV-2 immunization of nursing mothers transferred to infants as a potentially protective effect.

Digital Health Passes in the Age of COVID-19Are “Vaccine Passports” Lawful and Ethical?

Posted on by

JAMA
May 11, 2021, Vol 325, No. 18, Pages 1813-1912
https://jamanetwork.com/journals/jama/currentissue

 

Viewpoint
Digital Health Passes in the Age of COVID-19Are “Vaccine Passports” Lawful and Ethical?
Lawrence O. Gostin, JD; I. Glenn Cohen, JD; Jana Shaw, MD, MPH
free access
JAMA. 2021;325(19):1933-1934. doi:10.1001/jama.2021.5283
This Viewpoint discusses digital health passes (DHPs) that would grant access to work, entertainment, shopping, and travel with confirmation of COVID-19 immunity, and the scientific, legal, ethical, and equity considerations that must be worked through for DHPs to be considered effective and fair.

Incorporating Adult Evidence Into Pediatric Research and PracticeBayesian Designs to Expedite Obtaining Child-Specific Evidence

Posted on by

JAMA
May 11, 2021, Vol 325, No. 18, Pages 1813-1912
https://jamanetwork.com/journals/jama/currentissue

 

Viewpoint
Incorporating Adult Evidence Into Pediatric Research and PracticeBayesian Designs to Expedite Obtaining Child-Specific Evidence
Srinivas Murthy, MD, CM, MHSc; Patricia Fontela, MD; Scott Berry, PhD
free access
JAMA. 2021;325(19):1937-1938. doi:10.1001/jama.2020.25007
This Viewpoint proposes ways to use bayesian methods to integrate evidence from adult clinical trials into the conduct, interpretation, and application of pediatric trials to generate scientifically robust and clinically actionable data for the care of children at a pace comparable with that for adults

The value of evidence synthesis

Posted on by

Nature Human Behaviour
Volume 5 Issue 5, May 2021
https://www.nature.com/nathumbehav/volumes/5/issues/5

 

Editorial | 20 May 2021
The value of evidence synthesis
Science is a cumulative enterprise, and systematic evidence synthesis is invaluable for appraising what is known and what is not known on a specific research question. We strongly encourage the submission of systematic reviews and meta-analyses to Nature Human Behaviour.

Socioeconomic impacts of COVID-19 in low-income countries

Posted on by

Nature Human Behaviour
Volume 5 Issue 5, May 2021
https://www.nature.com/nathumbehav/volumes/5/issues/5

 

Article | 30 March 2021
Socioeconomic impacts of COVID-19 in low-income countries
Recent phone survey data from Ethiopia, Malawi, Nigeria and Uganda reveals the breadth of the socioeconomic impacts of the COVID-19 pandemic on individuals and households.
Anna Josephson, Talip Kilic, Jeffrey D. Michler

Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant

Posted on by

New England Journal of Medicine
May 20, 2021 Vol. 384 No. 20
http://www.nejm.org/toc/nejm/medical-journal

 

Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant
Vivek Shinde, M.D., M.P.H., et al for the 2019nCoV-501 Study Group*
Conclusions
The NVX-CoV2373 vaccine was efficacious in preventing Covid-19, with higher vaccine efficacy observed among HIV-negative participants. Most infections were caused by the B.1.351 variant. (Funded by Novavax and the Bill and Melinda Gates Foundation; ClinicalTrials.gov number, NCT04533399. opens in new tab.)

Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant

Posted on by

New England Journal of Medicine
May 20, 2021 Vol. 384 No. 20
http://www.nejm.org/toc/nejm/medical-journal

 

Original Articles
Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant
Shabir A. Madhi, Ph.D., et al for the NGS-SA Group, and the Wits-VIDA COVID Group*
Conclusions
A two-dose regimen of the ChAdOx1 nCoV-19 vaccine did not show protection against mild-to-moderate Covid-19 due to the B.1.351 variant. (Funded by the Bill and Melinda Gates Foundation and others; ClinicalTrials.gov number, NCT04444674. opens in new tab; Pan African Clinical Trials Registry number, PACTR202006922165132. opens in new tab).

Opinion: Compound risks and complex emergencies require new approaches to preparedness

Posted on by

PNAS – Proceedings of the National Academy of Sciences of the United States of America
May 11, 2021; vol. 118 no. 19
https://www.pnas.org/content/118/19

 

Opinion
Leading scientists discuss current issues
Opinion: Compound risks and complex emergencies require new approaches to preparedness
A. Kruczkiewicz, J. Klopp, J. Fisher, S. Mason, S. McClain, N. M. Sheekh, R. Moss, R. M. Parks, and C. Braneon
PNAS May 11, 2021 118 (19) e2106795118; https://doi.org/10.1073/pnas.2106795118
Increasingly, we face compounding and interrelated environmental, socioeconomic, and political crises. Yet our approaches to these problems are often siloed, fragmented, and inadequate. The current pandemic, for instance, continues to collide with a number of other threats to human life and livelihoods. These include violent conflicts, displacement, insect swarms, droughts, heat waves, and structural inequality in the form of racism and gender discrimination. We believe we are at a critical juncture, faced with a need and responsibility to redesign institutions to be proactive, agile, and socially just when confronted with increasingly likely compound risks…

Global Systemic Risk and Resilience for Novel Coronavirus and COVID-19

Posted on by

Risk Analysis
Volume 41, Issue 5 Pages: 701-841 May 2021
https://onlinelibrary.wiley.com/toc/15396924/current

 

Special Issue: Global Systemic Risk and Resilience for Novel Coronavirus and COVID‐19: Part 1
Editorial Free Access
Global Systemic Risk and Resilience for Novel Coronavirus and COVID-19
Desheng Dash Wu, Jade Mitchell, James H. Lambert
Pages: 701-704
First Published: 17 May 2021

Impact of reduced human papillomavirus vaccination coverage rates due to COVID-19 in the United States: A model based analysis

Posted on by

Vaccine
Volume 39, Issue 20 Pages 2731-2810 (12 May 2021)
https://www.sciencedirect.com/journal/vaccine/vol/39/issue/20

 

Short communication Open access
Impact of reduced human papillomavirus vaccination coverage rates due to COVID-19 in the United States: A model based analysis
Vincent Daniels, Kunal Saxena, Craig Roberts, Smita Kothari, … Linda Niccolai
Pages 2731-2735

Hesitancy towards COVID-19 Vaccination among Healthcare Workers: A Multi-Centric Survey in France

Posted on by

Vaccines — Open Access Journal
http://www.mdpi.com/journal/vaccines

 

(Accessed 22 May 2021)
Open Access Article
Hesitancy towards COVID-19 Vaccination among Healthcare Workers: A Multi-Centric Survey in France
by Cécile Janssen et al and on behalf of the ACV Alpin Study Group
Vaccines 2021, 9(6), 547; https://doi.org/10.3390/vaccines9060547 (registering DOI) – 22 May 2021
Abstract
Vaccination programs against COVID-19 are being scaled up. We aimed to assess the effects of vaccine characteristics on vaccine hesitancy among healthcare workers in a multi-center survey conducted within French healthcare facilities from 1 December 2020 to 26 March 2021. We invited any […]

COVID-19 Vaccine Acceptability and Adherence to Preventive Measures in Somalia: Results of an Online Survey

Posted on by

Vaccines — Open Access Journal
http://www.mdpi.com/journal/vaccines

 

Open Access Article
COVID-19 Vaccine Acceptability and Adherence to Preventive Measures in Somalia: Results of an Online Survey
by Mohammed A. M. Ahmed et al
Vaccines 2021, 9(6), 543; https://doi.org/10.3390/vaccines9060543 (registering DOI) – 21 May 2021
Abstract
Most countries are currently gravitating towards vaccination as mainstay strategy to quell COVID-19 transmission. Between December 2020 and January 2021, we conducted a follow-up online survey in Somalia to monitor adherence to COVID-19 preventive measures, and COVID-19 vaccine acceptability and reasons for vaccine [..

COVID-19 Pandemic and Equal Access to Vaccines

Posted on by

Vaccines — Open Access Journal
http://www.mdpi.com/journal/vaccines

 

Open Access Commentary
COVID-19 Pandemic and Equal Access to Vaccines
by Matteo Bolcato et al
Vaccines 2021, 9(6), 538; https://doi.org/10.3390/vaccines9060538 (registering DOI) – 21 May 2021
Abstract
The COVID-19 pandemic has evidenced the chronic inequality that exists between populations and communities as regards global healthcare. Vaccination, an appropriate tool for the prevention of infection, should be guaranteed by means of proportionate interventions to defeat such inequality in populations and communities […

Knowledge, Attitudes and Perceptions of COVID-19 Vaccination among Healthcare Workers of an Inner-City Hospital in New York

Posted on by

Vaccines — Open Access Journal
http://www.mdpi.com/journal/vaccines

 

Open Access Article
Knowledge, Attitudes and Perceptions of COVID-19 Vaccination among Healthcare Workers of an Inner-City Hospital in New York
by Federico Ciardi et al
Vaccines 2021, 9(5), 516; https://doi.org/10.3390/vaccines9050516 – 17 May 2021
Abstract
Introduction: New York City is one of the areas most affected by the COVID-19 pandemic in the United States. Healthcare workers are among those at high risk of contracting the virus, and a vital source of information and trust in vaccines to the […]

Factors Affecting COVID-19 Vaccine Acceptance: An International Survey among Low- and Middle-Income Countries

Posted on by

Vaccines — Open Access Journal
http://www.mdpi.com/journal/vaccines

 

Open Access Article
Factors Affecting COVID-19 Vaccine Acceptance: An International Survey among Low- and Middle-Income Countries
by Suzanna Awang Bono et al
Vaccines 2021, 9(5), 515; https://doi.org/10.3390/vaccines9050515 – 17 May 2021
Abstract
Vaccination is fast becoming a key intervention against the ongoing COVID-19 pandemic. We conducted cross-sectional online surveys to investigate COVID-19 vaccine acceptance across nine Low- and Middle-Income Countries (LMICs; N = 10,183), assuming vaccine effectiveness at 90% and 95%. The prevalence of vaccine […

Media/Policy Watch

Posted on by

Media/Policy Watch
This watch section is intended to alert readers to substantive news, analysis and opinion from the general media and selected think tanks and similar organizations on vaccines, immunization, global public health and related themes. Media Watch is not intended to be exhaustive, but indicative of themes and issues CVEP is actively tracking. This section will grow from an initial base of newspapers, magazines and blog sources, and is segregated from Journal Watch above which scans the peer-reviewed journal ecology.
We acknowledge the Western/Northern bias in this initial selection of titles and invite suggestions for expanded coverage. We are conservative in our outlook in adding news sources which largely report on primary content we are already covering above. Many electronic media sources have tiered, fee-based subscription models for access. We will provide full-text where content is published without restriction, but most publications require registration and some subscription level.
The sheer volume of vaccine and pandemic-related coverage is extraordinary. We will strive to present the most substantive analysis and commentary we encounter.

 

The Atlantic
http://www.theatlantic.com/magazine/
Accessed 22 May 2021
[No new, unique, relevant content]

 

BBC
http://www.bbc.co.uk/
Accessed 22 May 2021
[No new, unique, relevant content]

 

The Economist
http://www.economist.com/
Accessed 22 May 2021
[No new, unique, relevant content]

 

Financial Times
https://www.ft.com/
Accessed 22 May 2021
Gordon Brown: G7 must bear the burden of vaccinating the world
May 21, 2021
Top of Form
Bottom of Form

Covid-19 vaccines
IMF says $50bn is needed to end Covid pandemic in 2022
May 21, 2021
Top of Form
Bottom of Form

COVAX
Covax scrambles to make up vaccine shortfall due to Indian export halt
Serum Institute of India was due to provide more than a third of the scheme’s forecast supply of doses for 2021
May 21, 2021

 

Forbes
http://www.forbes.com/
Accessed 22 May 2021
May 20, 2021
Over 75% Of Canadians May Need To Be Vaccinated Before Canada-U.S. Border Reopens
Over 75% of Canadians may need to be vaccinated before Canada-U.S. border can be opened.
By Sandra MacGregor Contributor

 

Foreign Affairs
http://www.foreignaffairs.com/
Accessed 22 May 2021
Snapshot May 21, 2021
U.S. Global Health Leadership Must Go Beyond Command and Control
The United States neither can nor should abdicate a strong leadership role in global health. The question is how it leads.
Jonathan Cohen

 

Foreign Policy
http://foreignpolicy.com/
Accessed 22 May 2021
Latin America’s Vaccine Stars and Struggles
Technology transfers to produce shots are slowly underway in the region.
By Catherine Osborn May 21, 2021

 

New Yorker
http://www.newyorker.com/
Accessed 22 May 2021
Medical Dispatch
The Struggle to Improve Vaccination Rates Among Latinos in New York
Vast disparities in immunization levels persist between the city’s communities.
By Stephania Taladrid 6:00 A.M.

 

New York Times
http://www.nytimes.com/
Accessed 22 May 2021
U.S.
Vaccinations are lagging at many U.S. prisons, where major virus outbreaks have been common.
Only two in five federal inmates have gotten at least one shot so far, compared with three-fifths of adults nationwide. Despite the elevated risk behind bars, mistrust and refusal rates run high.
By Ann Hinga Klein and Maura Turcotte May 22, 2021

Asia Pacific
Pakistan’s Private Vaccine Sales Highlight Rich-Poor Divide
An inoculation push, plagued with limited supplies and red tape, makes doses available to those who can pay for them. In a country with a struggling economy, most can’t.
By Salman Masood May 22, 2021

Politics
100 Million Vaccine Doses Held Up Over Contamination Concerns, Firm Reveals
Executives from Emergent, which ruined millions of coronavirus vaccine doses, divulged to Congress the scope of the regulatory review of its troubled Baltimore plant.
By Sheryl Gay Stolberg and Sharon LaFraniere May 22, 2021

World
A vaccine maker in India signals it won’t export doses before year’s end, slowing aid to the world’s poorest.
By Sameer Yasir May 19, 2021
The vaccination woes of some of the world’s poorest nations will continue as the Serum Institute of India, a crucial manufacturing pillar in the plan to supply two billion doses of Covid-19 vaccines to low-income countries, signaled that it would not be able to provide vaccines beyond India before the year’s end.
The revelation, tucked into a statement by the vaccine manufacturing giant that attempted to deflect mounting criticism, was another setback for Covax, the global vaccine partnership for the poor. It is already more than 140 million doses behind schedule, and the Serum Institute’s announcement suggested it was all but impossible to meet the goal of two billion doses by the end of the year.
The announcement once again underscored the glaring contrast of inequality: As some of the richer nations tout levels of vaccinations that allow them to reopen their society, most of the poorer nations have barely gotten a start.
“We continue to scale up manufacturing and prioritize India,” the Serum Institute of India said in the statement on Tuesday. “We also hope to start delivering to Covax and other countries by the end of this year.”…

 

Washington Post
https://www.washingtonpost.com/
Accessed 22 May 2021
Biden says U.S. will provide coronavirus vaccines for 550,000 South Korean troops
In a joint news conference with South Korean President Moon Jae-in, President Biden pledged to provide vaccines for 550,000 South Korean soldiers who work with American forces. Biden and Moon also discussed a possible partnership on coronavirus vaccine manufacturing.
Politics · May 21, 2021

Think Tanks et al

Posted on by

Think Tanks et al
 
 
Brookings
http://www.brookings.edu/
Accessed 22 May 2021
[No new digest content]
 
 
Center for Global Development [to 22 May 2021]
http://www.cgdev.org/page/press-center
Content
Dear President Biden and Congress: Time for US to Lead Response to the Growing COVID-19 Global Vaccine Crisis
May 17, 2021
Today we joined colleagues from CSIS, Duke University, and the COVID Collective in an open letter to the Biden Administration and US Congress with a clear message: to hasten the end of the COVID-19 global pandemic, American leadership is required to ensure universal global access to high-quality and safe vaccines, support rapid vaccine distribution and administration, and build a sustainable global network of vaccine manufacturing capacity. Vaccines offer an exit route out of the pandemic – but only if they reach a critical mass of people in need across continents, socioeconomic strata, and marginalized populations.
Amanda Glassman, Rachel Silverman and Prashant Yadav

Chatham House [to 22 May 2021]
https://www.chathamhouse.org/
Accessed 22 May 2021
[No new digest content]

 
 

CSIS
https://www.csis.org/
Accessed 22 May 2021
Report
Open Letter Calling for Urgent High-Level US Leadership to Address Escalating Global COVID-19 Vaccine Crisis
May 17, 2021

 
 
Kaiser Family Foundation
https://www.kff.org/search/?post_type=press-release
Accessed 22 May 2021
May 20, 2021 News Release
New Campaign from THE CONVERSATION / LA CONVERSACIÓN Responds to Information Needs about COVID-19 Vaccines Among Latinos and Spanish-speaking People in U.S.
News Release May 20, 2021 – THE CONVERSATION / LA CONVERSACIÓN expands to address information needs about the COVID-19 vaccines in the Latinx community with new videos featuring doctors, nurses and promotoras (community health workers) in English and Spanish. This installment of the campaign is produced by KFF (Kaiser Family…

Vaccines and Global Health: The Week in Review :: 15 May 2021

Posted on by

Posted on 

Vaccines and Global Health: The Week in Review is a weekly digest  summarizing news, events, announcements, peer-reviewed articles and research in the global vaccine ethics and policy space. Content is aggregated from key governmental, NGO, international organization and industry sources, key peer-reviewed journals, and other media channels. This summary proceeds from the broad base of themes and issues monitored by the Center for Vaccine Ethics & Policy in its work: it is not intended to be exhaustive in its coverage. You are viewing the blog version of our weekly digest, typically comprised of between 30 and 40 posts below all dated with the current issue date

.– Request an Email Summary: Vaccines and Global Health : The Week in Review is published as a single email summary, scheduled for release each Saturday evening before midnight (EDT in the U.S.). If you would like to receive the email version, please send your request to david.r.curry@centerforvaccineethicsandpolicy.org.

– pdf version:  A pdf of the current issue is available here: 

vaccines-and-global-health_the-week-in-review_15-may-2021Download

– blog edition: comprised of the approx. 35+ entries posted below.

– Twitter:  Readers can also follow developments on twitter: @vaxethicspolicy.
.
– Links:  We endeavor to test each link as we incorporate it into any post, but recognize that some links may become “stale” as publications and websites reorganize content over time. We apologize in advance for any links that may not be operative. We believe the contextual information in a given post should allow retrieval, but please contact us as above for assistance if necessary.

Support this knowledge-sharing service: Your financial support helps us cover our costs and to address a current shortfall in our annual operating budget. Click here to donate and thank you in advance for your contribution.

.
David R. Curry, MS
Executive Director
Center for Vaccine Ethics and Policy